Skip to main content
Top
Published in: BMC Cancer 1/2011

Open Access 01-12-2011 | Research article

The extramural metastasis might be categorized in lymph node staging for colorectal cancer

Authors: Hai-Bo Qiu, Gong Chen, Rajiv P Keshari, Hui-Yan Luo, Wang Fang, Miao-Zhen Qiu, Zhi-Wei Zhou, Rui-Hua Xu

Published in: BMC Cancer | Issue 1/2011

Login to get access

Abstract

Background

The objective of this study is to assess the clinical significance and prognostic impact of extramural metastasis in colorectal carcinoma and establish an optimal categorization in the staging system.

Methods

To determine the frequency and prognostic significance of extramural metastasis, from 2000 to 2005, a total of 1,215 patients with colorectal cancer who underwent surgical resection were recruited into this study. Individual demographic and clinicopathologic data were collected including tumor stage, nodal stage, tumor histology, degree of tumor differentiation, and presence of lymphovascular invasion. After surgery, all patients received standard treatments and follow-up, which were closed in April 2010.

Results

EM was detected in 167 (13.7%) patients and in 230 (1.8%) of the 12,534 nodules retrieved as 'lymph nodes'. The incidence of extramural metastasis was significantly higher in patients with large tumors, deeper invasive depth and more lymph node metastasis (P < 0.001). After curative operation, overall survival was significantly worse for patients with extramural metastasis than those without (P < 0.001). Multivariate analysis identified extramural metastasis as an independent prognostic factor (RR = 2.1, 95%CI:1.5-3.0). By using the Akaike information criterion (AIC), N staging was capable of predicting survival outcome with the highest accuracy when both nodal involvement and extramural metastasis were treated together as N factors(AIC = 1025.3).

Conclusion

Extramural metastasis might be diagnosed as replaced lymph nodes in the process of classification, thus forming a new categorization.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tanaka T, Kumagai K, Shimizu K, Masuo K, Yamagata K: Peritoneal metastasis in gastric cancer with particular reference to lymphatic advancement; extranodal invasion is a significant risk factor for peritoneal metastasis. J Surg Oncol. 2000, 75 (3): 165-171. 10.1002/1096-9098(200011)75:3<165::AID-JSO3>3.0.CO;2-5.CrossRefPubMed Tanaka T, Kumagai K, Shimizu K, Masuo K, Yamagata K: Peritoneal metastasis in gastric cancer with particular reference to lymphatic advancement; extranodal invasion is a significant risk factor for peritoneal metastasis. J Surg Oncol. 2000, 75 (3): 165-171. 10.1002/1096-9098(200011)75:3<165::AID-JSO3>3.0.CO;2-5.CrossRefPubMed
2.
go back to reference Etoh T, Sasako M, Ishikawa K, Katai H, Sano T, Shimoda T: Extranodal metastasis is an indicator of poor prognosis in patients with gastric carcinoma. Br J Surg. 2006, 93 (3): 369-373. 10.1002/bjs.5240.CrossRefPubMed Etoh T, Sasako M, Ishikawa K, Katai H, Sano T, Shimoda T: Extranodal metastasis is an indicator of poor prognosis in patients with gastric carcinoma. Br J Surg. 2006, 93 (3): 369-373. 10.1002/bjs.5240.CrossRefPubMed
3.
go back to reference Wind J, ten Kate FJ, Kiewiet JJ, Lagarde SM, Slors JF, van Lanschot JJ, Bemelman WA: The prognostic significance of extracapsular lymph node involvement in node positive patients with colonic cancer. Eur J Surg Oncol. 2008, 34 (4): 390-396. 10.1016/j.ejso.2007.05.011.CrossRefPubMed Wind J, ten Kate FJ, Kiewiet JJ, Lagarde SM, Slors JF, van Lanschot JJ, Bemelman WA: The prognostic significance of extracapsular lymph node involvement in node positive patients with colonic cancer. Eur J Surg Oncol. 2008, 34 (4): 390-396. 10.1016/j.ejso.2007.05.011.CrossRefPubMed
4.
go back to reference Goldstein NS, Turner JR: Pericolonic tumor deposits in patients with T3N+MO colon adenocarcinomas: markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification. Cancer. 2000, 88 (10): 2228-2238. 10.1002/(SICI)1097-0142(20000515)88:10<2228::AID-CNCR5>3.0.CO;2-1.CrossRefPubMed Goldstein NS, Turner JR: Pericolonic tumor deposits in patients with T3N+MO colon adenocarcinomas: markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification. Cancer. 2000, 88 (10): 2228-2238. 10.1002/(SICI)1097-0142(20000515)88:10<2228::AID-CNCR5>3.0.CO;2-1.CrossRefPubMed
5.
go back to reference Fleming ID, C J, H D, Hutter RVP, et al: AJCC Cancer Staging Manual. 1998, Philadelphia: Lippincott-Raven, 5 Fleming ID, C J, H D, Hutter RVP, et al: AJCC Cancer Staging Manual. 1998, Philadelphia: Lippincott-Raven, 5
6.
go back to reference Greene F, PD FI, Fritz A: AJCC Cancer Staging Manual. 2002, New York: Springer-Verlag, 6CrossRef Greene F, PD FI, Fritz A: AJCC Cancer Staging Manual. 2002, New York: Springer-Verlag, 6CrossRef
7.
go back to reference Jass JR, O'Brien MJ, Riddell RH, Snover DC: Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Hum Pathol. 2007, 38 (4): 537-545. 10.1016/j.humpath.2006.11.009.CrossRefPubMed Jass JR, O'Brien MJ, Riddell RH, Snover DC: Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Hum Pathol. 2007, 38 (4): 537-545. 10.1016/j.humpath.2006.11.009.CrossRefPubMed
8.
go back to reference Sobin Leslie, G M, W C: TNM classification of malignant tumours. 2009, New York: Wiley-Blackwell, 7 Sobin Leslie, G M, W C: TNM classification of malignant tumours. 2009, New York: Wiley-Blackwell, 7
9.
go back to reference Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, et al: NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw. 2009, 7 (8): 778-831.PubMed Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, et al: NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw. 2009, 7 (8): 778-831.PubMed
10.
go back to reference Desch CE, Benson AB, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Pfister DG, Virgo KS, Petrelli NJ: Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005, 23 (33): 8512-8519. 10.1200/JCO.2005.04.0063.CrossRefPubMed Desch CE, Benson AB, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Pfister DG, Virgo KS, Petrelli NJ: Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005, 23 (33): 8512-8519. 10.1200/JCO.2005.04.0063.CrossRefPubMed
11.
go back to reference Akaike H: Information theory and an extension of the maximum likelihood principle. Proceedings of the Second International Symposium on Information Theory. Edited by: Petrov BC. 1973, Budapest, Hungary: Akademia Kiado, 267-281. Akaike H: Information theory and an extension of the maximum likelihood principle. Proceedings of the Second International Symposium on Information Theory. Edited by: Petrov BC. 1973, Budapest, Hungary: Akademia Kiado, 267-281.
12.
go back to reference Wunder JS, Healey JH, Davis AM, Brennan MF: A comparison of staging systems for localized extremity soft tissue sarcoma. Cancer. 2000, 88 (12): 2721-2730. 10.1002/1097-0142(20000615)88:12<2721::AID-CNCR10>3.0.CO;2-D.CrossRefPubMed Wunder JS, Healey JH, Davis AM, Brennan MF: A comparison of staging systems for localized extremity soft tissue sarcoma. Cancer. 2000, 88 (12): 2721-2730. 10.1002/1097-0142(20000615)88:12<2721::AID-CNCR10>3.0.CO;2-D.CrossRefPubMed
13.
go back to reference Zaniboni A, Labianca R: Adjuvant therapy for stage II colon cancer: an elephant in the living room?. Ann Oncol. 2004, 15 (9): 1310-1318. 10.1093/annonc/mdh342.CrossRefPubMed Zaniboni A, Labianca R: Adjuvant therapy for stage II colon cancer: an elephant in the living room?. Ann Oncol. 2004, 15 (9): 1310-1318. 10.1093/annonc/mdh342.CrossRefPubMed
14.
go back to reference Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA: Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005, 97 (3): 219-225. 10.1093/jnci/dji020.CrossRefPubMed Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA: Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005, 97 (3): 219-225. 10.1093/jnci/dji020.CrossRefPubMed
15.
go back to reference NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990, 264 (11): 1444-1450. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990, 264 (11): 1444-1450.
16.
go back to reference Scott N, Jackson P, al-Jaberi T, Dixon MF, Quirke P, Finan PJ: Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg. 1995, 82 (8): 1031-1033. 10.1002/bjs.1800820808.CrossRefPubMed Scott N, Jackson P, al-Jaberi T, Dixon MF, Quirke P, Finan PJ: Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg. 1995, 82 (8): 1031-1033. 10.1002/bjs.1800820808.CrossRefPubMed
17.
go back to reference Reynolds JV, Joyce WP, Dolan J, Sheahan K, Hyland JM: Pathological evidence in support of total mesorectal excision in the management of rectal cancer. Br J Surg. 1996, 83 (8): 1112-1115. 10.1002/bjs.1800830826.CrossRefPubMed Reynolds JV, Joyce WP, Dolan J, Sheahan K, Hyland JM: Pathological evidence in support of total mesorectal excision in the management of rectal cancer. Br J Surg. 1996, 83 (8): 1112-1115. 10.1002/bjs.1800830826.CrossRefPubMed
18.
go back to reference Koike H, Ichikawa D, Kitamura K, Tsuchihashi Y, Yamagishi H: Perinodal involvement of cancer cells in gastric cancer patients. Surgery. 2004, 135 (3): 266-272. 10.1016/j.surg.2003.08.017.CrossRefPubMed Koike H, Ichikawa D, Kitamura K, Tsuchihashi Y, Yamagishi H: Perinodal involvement of cancer cells in gastric cancer patients. Surgery. 2004, 135 (3): 266-272. 10.1016/j.surg.2003.08.017.CrossRefPubMed
19.
go back to reference Burnham KP, A D: Model selection and multimodel inference: a practical information-theoretic approach. 2006, Colorado: Colorado Cooperative Fisher and Wildlife Research Unit, 2 Burnham KP, A D: Model selection and multimodel inference: a practical information-theoretic approach. 2006, Colorado: Colorado Cooperative Fisher and Wildlife Research Unit, 2
20.
go back to reference Jass JR, Love SB, Northover JM: A new prognostic classification of rectal cancer. Lancet. 1987, 1 (8545): 1303-1306.CrossRefPubMed Jass JR, Love SB, Northover JM: A new prognostic classification of rectal cancer. Lancet. 1987, 1 (8545): 1303-1306.CrossRefPubMed
21.
go back to reference Ueno H, Mochizuki H, Hashiguchi Y, Ishiguro M, Miyoshi M, Kajiwara Y, Sato T, Shimazaki H, Hase K: Extramural cancer deposits without nodal structure in colorectal cancer: optimal categorization for prognostic staging. Am J Clin Pathol. 2007, 127 (2): 287-294. 10.1309/903UT10VQ3LC7B8L.CrossRefPubMed Ueno H, Mochizuki H, Hashiguchi Y, Ishiguro M, Miyoshi M, Kajiwara Y, Sato T, Shimazaki H, Hase K: Extramural cancer deposits without nodal structure in colorectal cancer: optimal categorization for prognostic staging. Am J Clin Pathol. 2007, 127 (2): 287-294. 10.1309/903UT10VQ3LC7B8L.CrossRefPubMed
Metadata
Title
The extramural metastasis might be categorized in lymph node staging for colorectal cancer
Authors
Hai-Bo Qiu
Gong Chen
Rajiv P Keshari
Hui-Yan Luo
Wang Fang
Miao-Zhen Qiu
Zhi-Wei Zhou
Rui-Hua Xu
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2011
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-11-414

Other articles of this Issue 1/2011

BMC Cancer 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine